BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7036497)

  • 1. Quantitation of platelet lysis, platelet consumption on oxygenator, and stabilization of platelet membrane with prostacyclin and ibuprofen during cardiopulmonary bypass surgery in dogs.
    Dewanjee MK; Vogel SR; Peterson KA; Lim MF; Kaye MP
    Trans Am Soc Artif Intern Organs; 1981; 27():197-202. PubMed ID: 7036497
    [No Abstract]   [Full Text] [Related]  

  • 2. Preservation of platelets and their function in prolonged cardiopulmonary bypass using prostacyclin.
    Koshal A; Krausz MM; Utsunomiya T; Hechtman HB; Collins JJ; Cohn LH
    Circulation; 1981 Aug; 64(2 Pt 2):II44-8. PubMed ID: 7018736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preservation of platelet function and number by prostacyclin during cardiopulmonary bypass.
    Coppe D; Sobel M; Seamans L; Levine F; Salzman E
    J Thorac Cardiovasc Surg; 1981 Feb; 81(2):274-8. PubMed ID: 7005550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fate of indium 111-labeled platelets during cardiopulmonary bypass performed with membrane and bubble oxygenators.
    Peterson KA; Dewanjee MK; Kaye MP
    J Thorac Cardiovasc Surg; 1982 Jul; 84(1):39-43. PubMed ID: 7087539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet function during cardiac operation: comparison of membrane and bubble oxygenators.
    Edmunds LH; Ellison N; Colman RW; Niewiarowski S; Rao AK; Addonizio VP; Stephenson LW; Edie RN
    J Thorac Cardiovasc Surg; 1982 Jun; 83(6):805-12. PubMed ID: 7087507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet preservation during cardiopulmonary bypass (CPB) with prostaglandin (PGE1) and prostacyclin (PGI2).
    van den Dungen JJ; Velders AJ; Karliczek GF; Homan van der Heide JN; Wildevuur CR
    Trans Am Soc Artif Intern Organs; 1980; 26():481-6. PubMed ID: 7018057
    [No Abstract]   [Full Text] [Related]  

  • 7. [Platelet consumption and its prevention during cardiopulmonary bypass with a membrane oxygenator].
    Kawada T; Funaki S; Hoson M; Masaki H; Ando N; Osada H; Okada T; Hiekata T; Noguchi T
    Nihon Kyobu Geka Gakkai Zasshi; 1986 Sep; 34(9):1664-8. PubMed ID: 3794431
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention by a stable prostacyclin analogue, 7-oxoprostaglandin I2 of the platelet loss during experimental cardiopulmonary bypass.
    Juhász-Nagy S; Kékesi V; Sótonyi P; Moravcsik G; Kovács G
    Acta Chir Hung; 1988; 29(3):251-61. PubMed ID: 3071058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thromboxane synthesis and platelet secretion during cardiopulmonary bypass with bubble oxygenator.
    Addonizio VP; Smith JB; Strauss JF; Colman RW; Edmunds LH
    J Thorac Cardiovasc Surg; 1980 Jan; 79(1):91-6. PubMed ID: 7350392
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostacyclin inhibits 5-hydroxytryptamine release but stimulates thromboxane synthesis during cardiopulmonary bypass.
    Aznavoorian SA; Utsunomiya T; Krausz MM; Cohn LH; Shepro D; Hechtman HB
    Prostaglandins; 1983 Apr; 25(4):557-70. PubMed ID: 6348886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of prostaglandin I2 derivative infusion during experimental cardiopulmonary bypass].
    Matsukura H; Takeda H; Uzawa S; Sakai K; Kawakami T; Tanabe T
    Nihon Kyobu Geka Gakkai Zasshi; 1983 Jun; 31(6):871-5. PubMed ID: 6352833
    [No Abstract]   [Full Text] [Related]  

  • 12. Blockage of partially obstructed coronary arteries with platelet thrombi: comparison between its prevention with cyclooxygenase inhibitors versus prostacyclin.
    Aiken JW; Shebuski RJ; Gorman RR
    Adv Prostaglandin Thromboxane Res; 1980; 7():635-9. PubMed ID: 6245568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood platelets and extracorporeal circulation; kinetic studies on dogs on cardiopulmonary bypass.
    de Leval MR; Hill JD; Mielke CH; Macur F; Gerbode F
    J Thorac Cardiovasc Surg; 1975 Jan; 69(1):144-51. PubMed ID: 1110575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Platelets and membrane oxygenators (plate and fiber)].
    Sargentini JC; Pommier J; Espriet G
    Ann Chir; 1986 Mar; 40(2):163-5. PubMed ID: 3740765
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostacyclin: a hormone with a therapeutic potential. The Sir Henry Dale Lecture for 1981.
    Vane JR
    J Endocrinol; 1982 Nov; 95(2):3P-43P. PubMed ID: 6816886
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of prostacyclin and albumin on platelet loss during in vitro simulation of extracorporeal circulation.
    Addonizio VP; Macarak J; Nicolaou KC; Edmunds LH; Colman RW
    Blood; 1979 Jun; 53(6):1033-42. PubMed ID: 375998
    [No Abstract]   [Full Text] [Related]  

  • 17. Prostacyclin eliminates the bioincompatibility of charcoal haemoperfusion.
    Weston MJ; Woods HF; Bunting S; Moncada S; Vane JR
    Proc Eur Dial Transplant Assoc; 1979; 16():225-31. PubMed ID: 398492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet loss during experimental cardiopulmonary bypass and its prevention with prostacyclin.
    Plachetka JR; Salomon NW; Larson DF; Copeland JG
    Ann Thorac Surg; 1980 Jul; 30(1):58-63. PubMed ID: 6994666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the effects of membrane and bubble oxygenators on platelet counts and platelet size in elective cardiac operations.
    Trumbull HR; Howe J; Mottl K; Nicoloff DM
    Ann Thorac Surg; 1980 Jul; 30(1):52-7. PubMed ID: 7396579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined administration of nitric oxide gas and iloprost during cardiopulmonary bypass reduces platelet dysfunction: a pilot clinical study.
    Chung A; Wildhirt SM; Wang S; Koshal A; Radomski MW
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):782-90. PubMed ID: 15821644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.